1-2 of 2
Hironori Harada
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A MAP1B–cortactin–Tks5 axis regulates TNBC invasion and tumorigenesis

Hiroki Inoue, Taku Kanda, Gakuto Hayashi, Ryota Munenaga, Masayuki Yoshida, Kana Hasegawa, Takuya Miyagawa, Yukiya Kurumada, Jumpei Hasegawa, Tomoyuki Wada, Motoi Horiuchi, Yasuhiro Yoshimatsu, Fumiko Itoh, Yuki Maemoto, Kohei Arasaki, Yuichi Wakana, Tetsuro Watabe, Hiromichi Matsushita, Hironori Harada, Mitsuo Tagaya
Journal: Journal of Cell Biology
J Cell Biol (2024) 223 (3): e202303102.
https://doi.org/10.1083/jcb.202303102
Published: 14 February 2024
View article titled, A MAP1B–cortactin–Tks5 axis regulates TNBC invasion and tumorigenesis
Open the PDF for A MAP1B–cortactin–Tks5 axis regulates TNBC invasion and tumorigenesis in another window
Includes: Supplementary data
Journal Articles

The loss of Ezh2 drives the pathogenesis of myelofibrosis and sensitizes tumor-initiating cells to bromodomain inhibition

Goro Sashida, Changshan Wang, Takahisa Tomioka, Motohiko Oshima, Kazumasa Aoyama, Akinori Kanai, Makiko Mochizuki-Kashio, Hironori Harada, Kazuya Shimoda, Atsushi Iwama
Journal: Journal of Experimental Medicine
J Exp Med (2016) 213 (8): 1459–1477.
https://doi.org/10.1084/jem.20151121
Published: 11 July 2016
View article titled, The loss of Ezh2 drives the pathogenesis of myelofibrosis and sensitizes tumor-initiating cells to bromodomain inhibition
Open the PDF for The loss of Ezh2 drives the pathogenesis of myelofibrosis and sensitizes tumor-initiating cells to bromodomain inhibition in another window
Includes: Supplementary data